Joseph Woodard
Hoofd Techniek/Wetenschap/O&O bij IMUGENE LIMITED
Actieve functies van Joseph Woodard
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| IMUGENE LIMITED | Hoofd Techniek/Wetenschap/O&O | 04-09-2023 | - |
Loopbaan van Joseph Woodard
Eerdere bekende functies van Joseph Woodard
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 11-01-2017 | 01-11-2019 |
Immune-Onc Therapeutics, Inc.
 Immune-Onc Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Joseph Woodard
| The University of North Carolina at Charlotte | Undergraduate Degree |
| UNC School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Australië | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| IMUGENE LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
Immune-Onc Therapeutics, Inc.
Immune-Onc Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA. | Health Technology |
- Beurs
- Insiders
- Joseph Woodard
- Ervaring
